NEW YORK (GenomeWeb) – Sequenom has published a clinical validation study of its MaterniT Genome test, a noninvasive prenatal test that evaluates genome-wide chromosomal copy number status.

The retrospective, blinded study included plasma samples from over 1,000 pregnant women at an increased risk for fetal chromosomal aneuploidy and was published online this month in the American Journal of Obstetrics and Gynecology.